nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—ABCG2—Conjugated Estrogens—osteoporosis	0.116	0.18	CbGbCtD
Topotecan—ABCG2—Estradiol—osteoporosis	0.102	0.158	CbGbCtD
Topotecan—ABCB1—Ethinyl Estradiol—osteoporosis	0.0572	0.0883	CbGbCtD
Topotecan—CYP3A4—Estropipate—osteoporosis	0.0532	0.0821	CbGbCtD
Topotecan—CYP3A4—Calcitriol—osteoporosis	0.0532	0.0821	CbGbCtD
Topotecan—CYP3A4—Ergocalciferol—osteoporosis	0.0425	0.0656	CbGbCtD
Topotecan—ABCB1—Conjugated Estrogens—osteoporosis	0.042	0.0648	CbGbCtD
Topotecan—ABCB1—Estradiol—osteoporosis	0.0368	0.0569	CbGbCtD
Topotecan—CYP3A4—Raloxifene—osteoporosis	0.0355	0.0548	CbGbCtD
Topotecan—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0343	0.0529	CbGbCtD
Topotecan—CYP3A4—Cholecalciferol—osteoporosis	0.0274	0.0423	CbGbCtD
Topotecan—CYP3A4—Conjugated Estrogens—osteoporosis	0.0251	0.0388	CbGbCtD
Topotecan—CYP3A4—Estradiol—osteoporosis	0.0221	0.0341	CbGbCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—GSN—osteoporosis	0.00118	0.183	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—ID4—osteoporosis	0.000881	0.137	CbGpPWpGaD
Topotecan—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000654	0.101	CbGpPWpGaD
Topotecan—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000403	0.0625	CbGpPWpGaD
Topotecan—Malaise—Zoledronate—osteoporosis	0.0004	0.00116	CcSEcCtD
Topotecan—Body temperature increased—Ibandronate—osteoporosis	0.0004	0.00116	CcSEcCtD
Topotecan—Abdominal pain—Ibandronate—osteoporosis	0.0004	0.00116	CcSEcCtD
Topotecan—Leukopenia—Zoledronate—osteoporosis	0.000397	0.00115	CcSEcCtD
Topotecan—Anaphylactic shock—Pamidronate—osteoporosis	0.000396	0.00115	CcSEcCtD
Topotecan—Haemoglobin—Estradiol—osteoporosis	0.000395	0.00114	CcSEcCtD
Topotecan—Infection—Pamidronate—osteoporosis	0.000394	0.00114	CcSEcCtD
Topotecan—Rhinitis—Estradiol—osteoporosis	0.000394	0.00114	CcSEcCtD
Topotecan—Urticaria—Calcitriol—osteoporosis	0.000393	0.00114	CcSEcCtD
Topotecan—Haemorrhage—Estradiol—osteoporosis	0.000393	0.00114	CcSEcCtD
Topotecan—Body temperature increased—Calcitriol—osteoporosis	0.000391	0.00113	CcSEcCtD
Topotecan—Abdominal pain—Calcitriol—osteoporosis	0.000391	0.00113	CcSEcCtD
Topotecan—Hypoaesthesia—Estradiol—osteoporosis	0.000391	0.00113	CcSEcCtD
Topotecan—Angioedema—Conjugated Estrogens—osteoporosis	0.00039	0.00113	CcSEcCtD
Topotecan—Pharyngitis—Estradiol—osteoporosis	0.00039	0.00113	CcSEcCtD
Topotecan—Hypersensitivity—Estropipate—osteoporosis	0.000389	0.00112	CcSEcCtD
Topotecan—Nervous system disorder—Pamidronate—osteoporosis	0.000389	0.00112	CcSEcCtD
Topotecan—Thrombocytopenia—Pamidronate—osteoporosis	0.000388	0.00112	CcSEcCtD
Topotecan—Vomiting—Etidronic acid—osteoporosis	0.000388	0.00112	CcSEcCtD
Topotecan—Cough—Zoledronate—osteoporosis	0.000387	0.00112	CcSEcCtD
Topotecan—Rash—Etidronic acid—osteoporosis	0.000384	0.00111	CcSEcCtD
Topotecan—Dermatitis—Etidronic acid—osteoporosis	0.000384	0.00111	CcSEcCtD
Topotecan—Hyperhidrosis—Pamidronate—osteoporosis	0.000383	0.00111	CcSEcCtD
Topotecan—Hypersensitivity—Alendronate—osteoporosis	0.000383	0.00111	CcSEcCtD
Topotecan—Headache—Etidronic acid—osteoporosis	0.000382	0.0011	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00038	0.0011	CcSEcCtD
Topotecan—Asthenia—Estropipate—osteoporosis	0.000378	0.00109	CcSEcCtD
Topotecan—Anorexia—Pamidronate—osteoporosis	0.000378	0.00109	CcSEcCtD
Topotecan—Chest pain—Zoledronate—osteoporosis	0.000378	0.00109	CcSEcCtD
Topotecan—Arthralgia—Zoledronate—osteoporosis	0.000378	0.00109	CcSEcCtD
Topotecan—Myalgia—Zoledronate—osteoporosis	0.000378	0.00109	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000375	0.00108	CcSEcCtD
Topotecan—Paraesthesia—Risedronate—osteoporosis	0.000374	0.00108	CcSEcCtD
Topotecan—Pruritus—Estropipate—osteoporosis	0.000373	0.00108	CcSEcCtD
Topotecan—Discomfort—Zoledronate—osteoporosis	0.000373	0.00108	CcSEcCtD
Topotecan—Asthenia—Alendronate—osteoporosis	0.000373	0.00108	CcSEcCtD
Topotecan—Hypersensitivity—Ibandronate—osteoporosis	0.000373	0.00108	CcSEcCtD
Topotecan—Cough—Conjugated Estrogens—osteoporosis	0.000373	0.00108	CcSEcCtD
Topotecan—Dyspnoea—Risedronate—osteoporosis	0.000372	0.00107	CcSEcCtD
Topotecan—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000369	0.00107	CcSEcCtD
Topotecan—Fatigue—Ethinyl Estradiol—osteoporosis	0.000369	0.00107	CcSEcCtD
Topotecan—Pruritus—Alendronate—osteoporosis	0.000368	0.00106	CcSEcCtD
Topotecan—Dyspepsia—Risedronate—osteoporosis	0.000367	0.00106	CcSEcCtD
Topotecan—Constipation—Ethinyl Estradiol—osteoporosis	0.000366	0.00106	CcSEcCtD
Topotecan—Hypersensitivity—Calcitriol—osteoporosis	0.000365	0.00105	CcSEcCtD
Topotecan—Arthralgia—Conjugated Estrogens—osteoporosis	0.000364	0.00105	CcSEcCtD
Topotecan—Myalgia—Conjugated Estrogens—osteoporosis	0.000364	0.00105	CcSEcCtD
Topotecan—Chest pain—Conjugated Estrogens—osteoporosis	0.000364	0.00105	CcSEcCtD
Topotecan—Asthenia—Ibandronate—osteoporosis	0.000363	0.00105	CcSEcCtD
Topotecan—Nausea—Etidronic acid—osteoporosis	0.000362	0.00105	CcSEcCtD
Topotecan—Anaphylactic shock—Zoledronate—osteoporosis	0.000362	0.00105	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000361	0.00104	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000361	0.00104	CcSEcCtD
Topotecan—Diarrhoea—Estropipate—osteoporosis	0.000361	0.00104	CcSEcCtD
Topotecan—Gastrointestinal disorder—Risedronate—osteoporosis	0.00036	0.00104	CcSEcCtD
Topotecan—Infection—Zoledronate—osteoporosis	0.00036	0.00104	CcSEcCtD
Topotecan—Fatigue—Risedronate—osteoporosis	0.000359	0.00104	CcSEcCtD
Topotecan—Pruritus—Ibandronate—osteoporosis	0.000358	0.00103	CcSEcCtD
Topotecan—Constipation—Risedronate—osteoporosis	0.000356	0.00103	CcSEcCtD
Topotecan—Pain—Risedronate—osteoporosis	0.000356	0.00103	CcSEcCtD
Topotecan—Angiopathy—Estradiol—osteoporosis	0.000356	0.00103	CcSEcCtD
Topotecan—Paraesthesia—Pamidronate—osteoporosis	0.000356	0.00103	CcSEcCtD
Topotecan—Diarrhoea—Alendronate—osteoporosis	0.000355	0.00103	CcSEcCtD
Topotecan—Asthenia—Calcitriol—osteoporosis	0.000355	0.00103	CcSEcCtD
Topotecan—Nervous system disorder—Zoledronate—osteoporosis	0.000355	0.00103	CcSEcCtD
Topotecan—Immune system disorder—Estradiol—osteoporosis	0.000355	0.00103	CcSEcCtD
Topotecan—Thrombocytopenia—Zoledronate—osteoporosis	0.000354	0.00102	CcSEcCtD
Topotecan—Mediastinal disorder—Estradiol—osteoporosis	0.000354	0.00102	CcSEcCtD
Topotecan—Dyspnoea—Pamidronate—osteoporosis	0.000353	0.00102	CcSEcCtD
Topotecan—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000352	0.00102	CcSEcCtD
Topotecan—Chills—Estradiol—osteoporosis	0.000352	0.00102	CcSEcCtD
Topotecan—Skin disorder—Zoledronate—osteoporosis	0.000352	0.00102	CcSEcCtD
Topotecan—Pruritus—Calcitriol—osteoporosis	0.00035	0.00101	CcSEcCtD
Topotecan—Hyperhidrosis—Zoledronate—osteoporosis	0.00035	0.00101	CcSEcCtD
Topotecan—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00035	0.00101	CcSEcCtD
Topotecan—Diarrhoea—Raloxifene—osteoporosis	0.00035	0.00101	CcSEcCtD
Topotecan—Dyspepsia—Pamidronate—osteoporosis	0.000349	0.00101	CcSEcCtD
Topotecan—Dizziness—Estropipate—osteoporosis	0.000349	0.00101	CcSEcCtD
Topotecan—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000348	0.00101	CcSEcCtD
Topotecan—Alopecia—Estradiol—osteoporosis	0.000347	0.001	CcSEcCtD
Topotecan—Infection—Conjugated Estrogens—osteoporosis	0.000346	0.001	CcSEcCtD
Topotecan—Diarrhoea—Ibandronate—osteoporosis	0.000346	0.001	CcSEcCtD
Topotecan—Anorexia—Zoledronate—osteoporosis	0.000345	0.000997	CcSEcCtD
Topotecan—Decreased appetite—Pamidronate—osteoporosis	0.000344	0.000996	CcSEcCtD
Topotecan—Dizziness—Alendronate—osteoporosis	0.000344	0.000993	CcSEcCtD
Topotecan—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000342	0.000989	CcSEcCtD
Topotecan—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000342	0.000988	CcSEcCtD
Topotecan—Malnutrition—Estradiol—osteoporosis	0.000342	0.000988	CcSEcCtD
Topotecan—Fatigue—Pamidronate—osteoporosis	0.000342	0.000988	CcSEcCtD
Topotecan—Gastrointestinal pain—Risedronate—osteoporosis	0.000341	0.000985	CcSEcCtD
Topotecan—Urticaria—Ethinyl Estradiol—osteoporosis	0.00034	0.000982	CcSEcCtD
Topotecan—Constipation—Pamidronate—osteoporosis	0.000339	0.00098	CcSEcCtD
Topotecan—Pain—Pamidronate—osteoporosis	0.000339	0.00098	CcSEcCtD
Topotecan—Diarrhoea—Calcitriol—osteoporosis	0.000339	0.000979	CcSEcCtD
Topotecan—Skin disorder—Conjugated Estrogens—osteoporosis	0.000339	0.000979	CcSEcCtD
Topotecan—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000338	0.000977	CcSEcCtD
Topotecan—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000338	0.000977	CcSEcCtD
Topotecan—Dizziness—Raloxifene—osteoporosis	0.000338	0.000977	CcSEcCtD
Topotecan—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000337	0.000974	CcSEcCtD
Topotecan—Vomiting—Estropipate—osteoporosis	0.000335	0.00097	CcSEcCtD
Topotecan—Dizziness—Ibandronate—osteoporosis	0.000334	0.000967	CcSEcCtD
Topotecan—Rash—Estropipate—osteoporosis	0.000333	0.000961	CcSEcCtD
Topotecan—Dermatitis—Estropipate—osteoporosis	0.000332	0.000961	CcSEcCtD
Topotecan—Anorexia—Conjugated Estrogens—osteoporosis	0.000332	0.00096	CcSEcCtD
Topotecan—Urticaria—Risedronate—osteoporosis	0.000331	0.000957	CcSEcCtD
Topotecan—Back pain—Estradiol—osteoporosis	0.000331	0.000956	CcSEcCtD
Topotecan—Headache—Estropipate—osteoporosis	0.00033	0.000955	CcSEcCtD
Topotecan—Vomiting—Alendronate—osteoporosis	0.00033	0.000955	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00033	0.000953	CcSEcCtD
Topotecan—Abdominal pain—Risedronate—osteoporosis	0.000329	0.000953	CcSEcCtD
Topotecan—Body temperature increased—Risedronate—osteoporosis	0.000329	0.000953	CcSEcCtD
Topotecan—Muscle spasms—Estradiol—osteoporosis	0.000329	0.00095	CcSEcCtD
Topotecan—Rash—Alendronate—osteoporosis	0.000328	0.000947	CcSEcCtD
Topotecan—Dermatitis—Alendronate—osteoporosis	0.000327	0.000946	CcSEcCtD
Topotecan—Feeling abnormal—Pamidronate—osteoporosis	0.000327	0.000944	CcSEcCtD
Topotecan—Headache—Alendronate—osteoporosis	0.000325	0.000941	CcSEcCtD
Topotecan—Paraesthesia—Zoledronate—osteoporosis	0.000325	0.00094	CcSEcCtD
Topotecan—Vomiting—Raloxifene—osteoporosis	0.000325	0.000939	CcSEcCtD
Topotecan—Gastrointestinal pain—Pamidronate—osteoporosis	0.000324	0.000937	CcSEcCtD
Topotecan—Dyspnoea—Zoledronate—osteoporosis	0.000323	0.000933	CcSEcCtD
Topotecan—Rash—Raloxifene—osteoporosis	0.000322	0.000931	CcSEcCtD
Topotecan—Dermatitis—Raloxifene—osteoporosis	0.000322	0.00093	CcSEcCtD
Topotecan—Vomiting—Ibandronate—osteoporosis	0.000322	0.00093	CcSEcCtD
Topotecan—Headache—Raloxifene—osteoporosis	0.00032	0.000925	CcSEcCtD
Topotecan—Rash—Ibandronate—osteoporosis	0.000319	0.000922	CcSEcCtD
Topotecan—Dermatitis—Ibandronate—osteoporosis	0.000319	0.000921	CcSEcCtD
Topotecan—Dyspepsia—Zoledronate—osteoporosis	0.000319	0.000921	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000318	0.000918	CcSEcCtD
Topotecan—Ill-defined disorder—Estradiol—osteoporosis	0.000317	0.000917	CcSEcCtD
Topotecan—Headache—Ibandronate—osteoporosis	0.000317	0.000916	CcSEcCtD
Topotecan—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000315	0.000911	CcSEcCtD
Topotecan—Vomiting—Calcitriol—osteoporosis	0.000315	0.00091	CcSEcCtD
Topotecan—Decreased appetite—Zoledronate—osteoporosis	0.000315	0.00091	CcSEcCtD
Topotecan—Nausea—Estropipate—osteoporosis	0.000313	0.000906	CcSEcCtD
Topotecan—Body temperature increased—Pamidronate—osteoporosis	0.000313	0.000906	CcSEcCtD
Topotecan—Abdominal pain—Pamidronate—osteoporosis	0.000313	0.000906	CcSEcCtD
Topotecan—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000313	0.000905	CcSEcCtD
Topotecan—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000312	0.000903	CcSEcCtD
Topotecan—Angioedema—Estradiol—osteoporosis	0.000312	0.000903	CcSEcCtD
Topotecan—Rash—Calcitriol—osteoporosis	0.000312	0.000903	CcSEcCtD
Topotecan—Fatigue—Zoledronate—osteoporosis	0.000312	0.000902	CcSEcCtD
Topotecan—Dermatitis—Calcitriol—osteoporosis	0.000312	0.000902	CcSEcCtD
Topotecan—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000311	0.000898	CcSEcCtD
Topotecan—Headache—Calcitriol—osteoporosis	0.00031	0.000897	CcSEcCtD
Topotecan—Pain—Zoledronate—osteoporosis	0.000309	0.000895	CcSEcCtD
Topotecan—Constipation—Zoledronate—osteoporosis	0.000309	0.000895	CcSEcCtD
Topotecan—Nausea—Alendronate—osteoporosis	0.000309	0.000892	CcSEcCtD
Topotecan—Malaise—Estradiol—osteoporosis	0.000308	0.000891	CcSEcCtD
Topotecan—Hypersensitivity—Risedronate—osteoporosis	0.000307	0.000888	CcSEcCtD
Topotecan—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000307	0.000887	CcSEcCtD
Topotecan—Asthenia—Ethinyl Estradiol—osteoporosis	0.000307	0.000887	CcSEcCtD
Topotecan—Nausea—Raloxifene—osteoporosis	0.000303	0.000877	CcSEcCtD
Topotecan—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000303	0.000876	CcSEcCtD
Topotecan—Pruritus—Ethinyl Estradiol—osteoporosis	0.000302	0.000874	CcSEcCtD
Topotecan—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000301	0.00087	CcSEcCtD
Topotecan—Fatigue—Conjugated Estrogens—osteoporosis	0.0003	0.000869	CcSEcCtD
Topotecan—Nausea—Ibandronate—osteoporosis	0.0003	0.000869	CcSEcCtD
Topotecan—Asthenia—Risedronate—osteoporosis	0.000299	0.000865	CcSEcCtD
Topotecan—Feeling abnormal—Zoledronate—osteoporosis	0.000298	0.000862	CcSEcCtD
Topotecan—Cough—Estradiol—osteoporosis	0.000298	0.000862	CcSEcCtD
Topotecan—Constipation—Conjugated Estrogens—osteoporosis	0.000298	0.000862	CcSEcCtD
Topotecan—Pain—Conjugated Estrogens—osteoporosis	0.000298	0.000862	CcSEcCtD
Topotecan—Gastrointestinal pain—Zoledronate—osteoporosis	0.000296	0.000856	CcSEcCtD
Topotecan—Pruritus—Risedronate—osteoporosis	0.000295	0.000853	CcSEcCtD
Topotecan—Nausea—Calcitriol—osteoporosis	0.000294	0.00085	CcSEcCtD
Topotecan—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000293	0.000846	CcSEcCtD
Topotecan—Hypersensitivity—Pamidronate—osteoporosis	0.000292	0.000844	CcSEcCtD
Topotecan—Chest pain—Estradiol—osteoporosis	0.000291	0.000841	CcSEcCtD
Topotecan—Myalgia—Estradiol—osteoporosis	0.000291	0.000841	CcSEcCtD
Topotecan—Arthralgia—Estradiol—osteoporosis	0.000291	0.000841	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000289	0.000835	CcSEcCtD
Topotecan—Urticaria—Zoledronate—osteoporosis	0.000288	0.000831	CcSEcCtD
Topotecan—Discomfort—Estradiol—osteoporosis	0.000287	0.000831	CcSEcCtD
Topotecan—Abdominal pain—Zoledronate—osteoporosis	0.000286	0.000827	CcSEcCtD
Topotecan—Body temperature increased—Zoledronate—osteoporosis	0.000286	0.000827	CcSEcCtD
Topotecan—Diarrhoea—Risedronate—osteoporosis	0.000285	0.000825	CcSEcCtD
Topotecan—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000285	0.000824	CcSEcCtD
Topotecan—Asthenia—Pamidronate—osteoporosis	0.000284	0.000822	CcSEcCtD
Topotecan—Dizziness—Ethinyl Estradiol—osteoporosis	0.000283	0.000817	CcSEcCtD
Topotecan—Pruritus—Pamidronate—osteoporosis	0.00028	0.00081	CcSEcCtD
Topotecan—Anaphylactic shock—Estradiol—osteoporosis	0.000279	0.000806	CcSEcCtD
Topotecan—Infection—Estradiol—osteoporosis	0.000277	0.000801	CcSEcCtD
Topotecan—Urticaria—Conjugated Estrogens—osteoporosis	0.000277	0.0008	CcSEcCtD
Topotecan—Dizziness—Risedronate—osteoporosis	0.000276	0.000797	CcSEcCtD
Topotecan—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000275	0.000797	CcSEcCtD
Topotecan—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000275	0.000797	CcSEcCtD
Topotecan—Nervous system disorder—Estradiol—osteoporosis	0.000274	0.000791	CcSEcCtD
Topotecan—Vomiting—Ethinyl Estradiol—osteoporosis	0.000272	0.000786	CcSEcCtD
Topotecan—Diarrhoea—Pamidronate—osteoporosis	0.000271	0.000784	CcSEcCtD
Topotecan—Skin disorder—Estradiol—osteoporosis	0.000271	0.000783	CcSEcCtD
Topotecan—Hyperhidrosis—Estradiol—osteoporosis	0.00027	0.00078	CcSEcCtD
Topotecan—Rash—Ethinyl Estradiol—osteoporosis	0.00027	0.000779	CcSEcCtD
Topotecan—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000269	0.000779	CcSEcCtD
Topotecan—Headache—Ethinyl Estradiol—osteoporosis	0.000268	0.000774	CcSEcCtD
Topotecan—Hypersensitivity—Zoledronate—osteoporosis	0.000267	0.000771	CcSEcCtD
Topotecan—Vomiting—Risedronate—osteoporosis	0.000265	0.000766	CcSEcCtD
Topotecan—Rash—Risedronate—osteoporosis	0.000263	0.00076	CcSEcCtD
Topotecan—Dermatitis—Risedronate—osteoporosis	0.000263	0.000759	CcSEcCtD
Topotecan—Dizziness—Pamidronate—osteoporosis	0.000262	0.000758	CcSEcCtD
Topotecan—Headache—Risedronate—osteoporosis	0.000261	0.000755	CcSEcCtD
Topotecan—Asthenia—Zoledronate—osteoporosis	0.00026	0.000751	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000259	0.0403	CbGpPWpGaD
Topotecan—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000257	0.000742	CcSEcCtD
Topotecan—Pruritus—Zoledronate—osteoporosis	0.000256	0.00074	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000254	0.000735	CcSEcCtD
Topotecan—Nausea—Ethinyl Estradiol—osteoporosis	0.000254	0.000734	CcSEcCtD
Topotecan—Vomiting—Pamidronate—osteoporosis	0.000252	0.000728	CcSEcCtD
Topotecan—Paraesthesia—Estradiol—osteoporosis	0.00025	0.000724	CcSEcCtD
Topotecan—Asthenia—Conjugated Estrogens—osteoporosis	0.00025	0.000723	CcSEcCtD
Topotecan—Rash—Pamidronate—osteoporosis	0.00025	0.000722	CcSEcCtD
Topotecan—Dermatitis—Pamidronate—osteoporosis	0.00025	0.000722	CcSEcCtD
Topotecan—Dyspnoea—Estradiol—osteoporosis	0.000249	0.000719	CcSEcCtD
Topotecan—Headache—Pamidronate—osteoporosis	0.000248	0.000718	CcSEcCtD
Topotecan—Diarrhoea—Zoledronate—osteoporosis	0.000248	0.000716	CcSEcCtD
Topotecan—Nausea—Risedronate—osteoporosis	0.000248	0.000716	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.000247	0.0384	CbGpPWpGaD
Topotecan—Pruritus—Conjugated Estrogens—osteoporosis	0.000247	0.000713	CcSEcCtD
Topotecan—Dyspepsia—Estradiol—osteoporosis	0.000246	0.00071	CcSEcCtD
Topotecan—Decreased appetite—Estradiol—osteoporosis	0.000242	0.000701	CcSEcCtD
Topotecan—Gastrointestinal disorder—Estradiol—osteoporosis	0.000241	0.000696	CcSEcCtD
Topotecan—Fatigue—Estradiol—osteoporosis	0.00024	0.000695	CcSEcCtD
Topotecan—Dizziness—Zoledronate—osteoporosis	0.000239	0.000692	CcSEcCtD
Topotecan—Pain—Estradiol—osteoporosis	0.000239	0.00069	CcSEcCtD
Topotecan—Constipation—Estradiol—osteoporosis	0.000239	0.00069	CcSEcCtD
Topotecan—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000238	0.000689	CcSEcCtD
Topotecan—Nausea—Pamidronate—osteoporosis	0.000235	0.00068	CcSEcCtD
Topotecan—Dizziness—Conjugated Estrogens—osteoporosis	0.00023	0.000666	CcSEcCtD
Topotecan—Vomiting—Zoledronate—osteoporosis	0.00023	0.000665	CcSEcCtD
Topotecan—Feeling abnormal—Estradiol—osteoporosis	0.00023	0.000665	CcSEcCtD
Topotecan—Rash—Zoledronate—osteoporosis	0.000228	0.00066	CcSEcCtD
Topotecan—Gastrointestinal pain—Estradiol—osteoporosis	0.000228	0.000659	CcSEcCtD
Topotecan—Dermatitis—Zoledronate—osteoporosis	0.000228	0.000659	CcSEcCtD
Topotecan—Headache—Zoledronate—osteoporosis	0.000227	0.000656	CcSEcCtD
Topotecan—Vomiting—Conjugated Estrogens—osteoporosis	0.000222	0.000641	CcSEcCtD
Topotecan—Urticaria—Estradiol—osteoporosis	0.000222	0.000641	CcSEcCtD
Topotecan—Abdominal pain—Estradiol—osteoporosis	0.00022	0.000637	CcSEcCtD
Topotecan—Body temperature increased—Estradiol—osteoporosis	0.00022	0.000637	CcSEcCtD
Topotecan—Rash—Conjugated Estrogens—osteoporosis	0.00022	0.000635	CcSEcCtD
Topotecan—Dermatitis—Conjugated Estrogens—osteoporosis	0.00022	0.000635	CcSEcCtD
Topotecan—Headache—Conjugated Estrogens—osteoporosis	0.000218	0.000631	CcSEcCtD
Topotecan—Nausea—Zoledronate—osteoporosis	0.000215	0.000622	CcSEcCtD
Topotecan—Nausea—Conjugated Estrogens—osteoporosis	0.000207	0.000598	CcSEcCtD
Topotecan—Hypersensitivity—Estradiol—osteoporosis	0.000205	0.000594	CcSEcCtD
Topotecan—Asthenia—Estradiol—osteoporosis	0.0002	0.000579	CcSEcCtD
Topotecan—Pruritus—Estradiol—osteoporosis	0.000197	0.000571	CcSEcCtD
Topotecan—Diarrhoea—Estradiol—osteoporosis	0.000191	0.000552	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000185	0.0287	CbGpPWpGaD
Topotecan—Dizziness—Estradiol—osteoporosis	0.000184	0.000533	CcSEcCtD
Topotecan—Vomiting—Estradiol—osteoporosis	0.000177	0.000513	CcSEcCtD
Topotecan—Rash—Estradiol—osteoporosis	0.000176	0.000508	CcSEcCtD
Topotecan—Dermatitis—Estradiol—osteoporosis	0.000176	0.000508	CcSEcCtD
Topotecan—Headache—Estradiol—osteoporosis	0.000175	0.000505	CcSEcCtD
Topotecan—Nausea—Estradiol—osteoporosis	0.000166	0.000479	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—TNF—osteoporosis	0.000143	0.0222	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.000134	0.0208	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—LEP—osteoporosis	0.000113	0.0175	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000112	0.0174	CbGpPWpGaD
Topotecan—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000104	0.0162	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—MTHFR—osteoporosis	9.77e-05	0.0152	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	9.69e-05	0.015	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	9.34e-05	0.0145	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—ENO1—osteoporosis	9.34e-05	0.0145	CbGpPWpGaD
Topotecan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	6.43e-05	0.00998	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	6e-05	0.00931	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.83e-05	0.00904	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.81e-05	0.00902	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.43e-05	0.00842	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—LEP—osteoporosis	5.22e-05	0.00811	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	5.11e-05	0.00793	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	5.05e-05	0.00784	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	5.04e-05	0.00782	CbGpPWpGaD
Topotecan—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	4.81e-05	0.00747	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—IL6—osteoporosis	4.2e-05	0.00652	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	4.14e-05	0.00643	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	3.69e-05	0.00573	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	3.32e-05	0.00515	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	3.29e-05	0.00511	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	2.82e-05	0.00438	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.76e-05	0.00428	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.68e-05	0.00417	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	2.67e-05	0.00414	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.65e-05	0.00411	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	2.2e-05	0.00341	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.18e-05	0.00338	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	2.17e-05	0.00337	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PKM—osteoporosis	1.97e-05	0.00305	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—FDPS—osteoporosis	1.97e-05	0.00305	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	1.9e-05	0.00295	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GPD2—osteoporosis	1.86e-05	0.00289	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PGLS—osteoporosis	1.86e-05	0.00289	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	1.78e-05	0.00276	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ATIC—osteoporosis	1.7e-05	0.00265	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PNP—osteoporosis	1.7e-05	0.00265	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.61e-05	0.0025	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL1B—osteoporosis	1.56e-05	0.00242	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.49e-05	0.00232	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CA2—osteoporosis	1.45e-05	0.00225	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—OXCT1—osteoporosis	1.45e-05	0.00225	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MGLL—osteoporosis	1.41e-05	0.00219	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.31e-05	0.00203	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TGFB1—osteoporosis	1.21e-05	0.00188	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—IDH2—osteoporosis	1.2e-05	0.00186	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.16e-05	0.00179	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.15e-05	0.00179	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.14e-05	0.00177	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TNF—osteoporosis	1.13e-05	0.00176	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP27A1—osteoporosis	1.13e-05	0.00175	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ACP5—osteoporosis	1.1e-05	0.00171	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PKM—osteoporosis	1.06e-05	0.00165	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—FDPS—osteoporosis	1.06e-05	0.00165	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.03e-05	0.00161	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TPI1—osteoporosis	1.02e-05	0.00159	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PGLS—osteoporosis	1.01e-05	0.00156	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GPD2—osteoporosis	1.01e-05	0.00156	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	9.97e-06	0.00155	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—P4HB—osteoporosis	9.6e-06	0.00149	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GAPDH—osteoporosis	9.43e-06	0.00146	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ATIC—osteoporosis	9.22e-06	0.00143	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PNP—osteoporosis	9.22e-06	0.00143	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—RAP1A—osteoporosis	9.18e-06	0.00142	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—OXCT1—osteoporosis	7.84e-06	0.00122	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CA2—osteoporosis	7.84e-06	0.00122	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MGLL—osteoporosis	7.64e-06	0.00119	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ENO1—osteoporosis	7.42e-06	0.00115	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PSMA5—osteoporosis	7.31e-06	0.00114	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PSMA2—osteoporosis	7.31e-06	0.00114	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—POMC—osteoporosis	6.94e-06	0.00108	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PKM—osteoporosis	6.55e-06	0.00102	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—FDPS—osteoporosis	6.55e-06	0.00102	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—IDH2—osteoporosis	6.49e-06	0.00101	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PGLS—osteoporosis	6.21e-06	0.000964	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GPD2—osteoporosis	6.21e-06	0.000964	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP27A1—osteoporosis	6.11e-06	0.000948	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.99e-06	0.00093	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.98e-06	0.000928	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ACP5—osteoporosis	5.94e-06	0.000922	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP19A1—osteoporosis	5.93e-06	0.000921	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ATIC—osteoporosis	5.68e-06	0.000881	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PNP—osteoporosis	5.68e-06	0.000881	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.6e-06	0.000868	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.58e-06	0.000866	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TPI1—osteoporosis	5.52e-06	0.000857	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—P4HB—osteoporosis	5.19e-06	0.000806	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GAPDH—osteoporosis	5.1e-06	0.000791	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—RAP1A—osteoporosis	4.96e-06	0.00077	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ADCY5—osteoporosis	4.85e-06	0.000752	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GPX1—osteoporosis	4.83e-06	0.00075	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—OXCT1—osteoporosis	4.83e-06	0.000749	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CA2—osteoporosis	4.83e-06	0.000749	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MGLL—osteoporosis	4.71e-06	0.00073	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTHFR—osteoporosis	4.46e-06	0.000692	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ENO1—osteoporosis	4.01e-06	0.000623	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—IDH2—osteoporosis	4e-06	0.000621	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PSMA2—osteoporosis	3.95e-06	0.000614	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PSMA5—osteoporosis	3.95e-06	0.000614	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.76e-06	0.000584	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ACP5—osteoporosis	3.66e-06	0.000568	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—POMC—osteoporosis	3.57e-06	0.000553	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TPI1—osteoporosis	3.4e-06	0.000528	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP19A1—osteoporosis	3.21e-06	0.000498	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—P4HB—osteoporosis	3.2e-06	0.000496	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GAPDH—osteoporosis	3.14e-06	0.000487	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—RAP1A—osteoporosis	3.06e-06	0.000475	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ADCY5—osteoporosis	2.62e-06	0.000407	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GPX1—osteoporosis	2.61e-06	0.000405	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ENO1—osteoporosis	2.47e-06	0.000384	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PSMA5—osteoporosis	2.44e-06	0.000378	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PSMA2—osteoporosis	2.44e-06	0.000378	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTHFR—osteoporosis	2.41e-06	0.000374	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.98e-06	0.000307	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—POMC—osteoporosis	1.93e-06	0.000299	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ADCY5—osteoporosis	1.61e-06	0.000251	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GPX1—osteoporosis	1.61e-06	0.00025	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTHFR—osteoporosis	1.49e-06	0.00023	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—POMC—osteoporosis	1.19e-06	0.000184	CbGpPWpGaD
